China Shineway Pharmaceutical Group Ltd. is an investment holding company, which engages in the research and development, manufacturing, and trading of Chinese pharmaceutical products. The company is headquartered in Shijiazhuang, Hebei and currently employs 3,220 full-time employees. The company went IPO on 2004-12-02. The Company’s product dosage forms include injections, soft capsules, granules, traditional Chinese medicine (TCM) granules, oral products and other dosage forms. The Company’s products include Qing Kai Ling Injection, Shen Mai Injection, Wu Fu Xin Nao Qing Soft Capsule, Qing Kai Ling Soft Capsule, Huamoyan Granule, Compound Licorice Tablet and other products, applied to influenza, cardio-cerebrovascular, respiratory system and other disease fields. The firm operates its business in mainland China and Hong Kong markets.
Follow-Up Questions
CSWYF 股票的价格表现如何？
CSWYF 的当前价格为 $0，在上个交易日 decreased 了 0%。
China Shineway Pharmaceutical Group Ltd 的主要业务主题或行业是什么？
China Shineway Pharmaceutical Group Ltd 属于 Pharmaceuticals 行业，该板块是 Health Care
China Shineway Pharmaceutical Group Ltd 的市值是多少？
China Shineway Pharmaceutical Group Ltd 的当前市值是 $0
China Shineway Pharmaceutical Group Ltd 是买入、卖出还是持有？
据华尔街分析师称，共有 4 位分析师对 China Shineway Pharmaceutical Group Ltd 进行了分析师评级，包括 3 位强烈买入，3 位买入，1 位持有，0 位卖出，以及 3 位强烈卖出
